Global 3D printing medical devices market to reach USD 5.9B by 2030

The “3D printing medical devices: Global strategic business report” report has been added to ResearchAndMarkets.com’s offering.

The global market for 3D printing medical devices estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$5.9 Billion by 2030, growing at a CAGR of 17.3% over the analysis period 2022-2030.

Systems, one of the segments analyzed in the report, is projected to record a 16.8% CAGR and reach US$3.2 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Materials segment is readjusted to a revised 18.9% CAGR for the next 8-year period.

The U.S. market is estimated at $584.2 Million, While China is forecast to grow at 18.6% CAGR
The 3D printing medical devices market in the U.S. is estimated at US$584.2 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$808.9 Million by the year 2030 trailing a CAGR of 18.6% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.3% and 16.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 17.8% CAGR.

Select competitors (Total 93 featured) –

• 3D Systems Corporation
• 3T Additive Manufacturing Ltd
• Anatomics Pty Ltd
• Biomedical Modeling Inc.
• Carbon, Inc.
• Cyfuse Biomedical K.K.
• EnvisionTEC GmbH
• EOS GmbH Electro Optical Systems
• Exone
• Formlabs
• General Electric Company
• Materialise NV
• Organovo Holdings, Inc.
• Oxferd Performance Materials, Inc.
• Prodways
• Proto Labs
• Renishaw plc
• SLM Solutions Group AG
• Stratasys Ltd.

Research and Markets